Literature DB >> 8389525

Nosocomial acquisition of Candida parapsilosis: an epidemiologic study.

V Sanchez1, J A Vazquez, D Barth-Jones, L Dembry, J D Sobel, M J Zervos.   

Abstract

OBJECTIVE: The purpose of this study was to determine aspects of the epidemiology of nosocomial infection due to Candida parapsilosis. Candida species are important nosocomial pathogens; however, little epidemiologic information is available. PATIENTS AND METHODS: We prospectively cultured specimens from 98 patients admitted to the bone marrow transplant unit and a medicine intensive care unit (ICU) of a tertiary care hospital. Specimens from hands of personnel and environmental surfaces were also cultured. Environmental cultures were done before patients were admitted to a studied unit. Restriction enzyme analysis (REA) of chromosomal DNA was used as a typing system to determine the relatedness of strains.
RESULTS: C. parapsilosis was identified from five patients, six hand cultures from four hospital staff, and two environmental surfaces. All five patients had negative initial cultures and acquired C. parapsilosis after admission to the study unit. There were no significant differences between patients and control subjects in age, underlying disease, immunosuppressive therapy, and instrumentation. The duration of antibiotic therapy (median: 32.8 versus 11.8 days, p = 0.05) and the duration in the unit (means: 30.1 versus 16.1 days, p = 0.048) was longer in patients than in controls. No common source was identified. REA revealed three strain types; however, one strain type was identical in four patients, three staff members, and two environmental surfaces.
CONCLUSION: These results suggest exogenous acquisition of C. parapsilosis. Based upon isolation of identical patient strains of C. parapsilosis from inanimate surfaces before patients were admitted to a study unit, there is evidence that the organism may have been acquired from the hospital environment. The principal mechanism of transmission was probably indirect contact via the hands of hospital personnel.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389525     DOI: 10.1016/0002-9343(93)90207-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

1.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  The microbial colonization profile of respiratory devices and the significance of the role of disinfection: a blinded study.

Authors:  Savita Jadhav; Tushar Sahasrabudhe; Vipul Kalley; Nageswari Gandham
Journal:  J Clin Diagn Res       Date:  2013-05-11

5.  The order of ward rounds influences nosocomial infection. A 2-year study in gastroenterologic surgery patients.

Authors:  J Yoshida; S Kuroki; K Akazawa; K Chijiiwa; K Takemori; M Torisu; M Tanaka
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

6.  Nosocomial Candida glabrata colonization: an epidemiologic study.

Authors:  J A Vazquez; L M Dembry; V Sanchez; M A Vazquez; J D Sobel; C Dmuchowski; M J Zervos
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

7.  Evaluation of the adherence of Candida species to urinary catheters.

Authors:  N K Tamura; A Gasparetto; T I E Svidzinski
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

Review 8.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  In vitro synergistic activity of diketopiperazines alone and in combination with amphotericin B or clotrimazole against Candida albicans.

Authors:  S Nishanth Kumar; Bala Nambisan; C Mohandas; A Sundaresan
Journal:  Folia Microbiol (Praha)       Date:  2013-02-28       Impact factor: 2.099

10.  Genotypic analysis of pseudoepidemic due to contamination of Hanks' balanced salt solution with Candida parapsilosis.

Authors:  S C Deresinski; K V Clemons; C A Kemper; K Roesch; B Walton; D A Stevens
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.